(Q52078708)

21 April 2018

title

Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients. (English)

1 reference

21 April 2018

author name string

Yeh FL

series ordinal

1

1 reference

21 April 2018

Lin WL

series ordinal

2

1 reference

21 April 2018

Shen HD

series ordinal

3

1 reference

21 April 2018

publication date

1 August 2000

1 reference

21 April 2018

published in

Burns

1 reference

21 April 2018

volume

26

1 reference

21 April 2018

issue

5

1 reference

21 April 2018

page(s)

454-459

1 reference

21 April 2018

The role of mediators in the response to thermal injury

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Changes in serum tumour necrosis factor-alpha in burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Changes in levels of serum IL-8 in burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Changes in circulating levels of interleukin 6 in burned patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Interleukin 10 protects mice from lethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Interleukin-10 Is Associated with the Development of Sepsis in Trauma Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Nitric oxide inhibition normalizes splenocyte interleukin-10 synthesis in murine thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2899%2900174-6

7 January 2021

10.1016/S0305-4179(99)00174-6

Identifiers

DOI

1 reference

21 April 2018

1 reference

21 April 2018